| Financial Year |
March 31 2023 |
| Monetary Funds |
656,924,005.25 |
| Held-for-trading Financial Assets |
177,541,173.08 |
| Notes Receivable |
-- |
| Accounts Receivable |
561,835.74 |
| Advances to Suppliers |
7,412,517.26 |
| Other Receivables |
87,788,792.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,704,434,221.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
20,189,450.31 |
| Other Current Assets |
94,555,130.65 |
| Total Current Assets |
5,749,407,126.94 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
204,678,922.25 |
| Long-term Equity Investment |
-- |
| Investment Properties |
440,554,048.49 |
| Fixed Assetes |
14,644,199.04 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,628,385.35 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
951,428.09 |
| Deferred Income Tax Assets |
32,215,625.14 |
| Other Non-Current Assets |
32,288,262.65 |
| Sub-Total of Non-Current Assets |
2,261,822,416.63 |
| Total Assets |
8,011,229,543.57 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
87,761,086.84 |
| Accounts Received In Advance |
7,130,326.29 |
| Employee Compensation Payable |
1,823,689.59 |
| Taxes Payable |
34,836,395.67 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,520,044,649.95 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
302,512,195.31 |
| Other Current Liabilities |
12,764,647.12 |
| Sub-Total of Current Liabilities |
2,109,199,816.05 |
| Long-term Loans |
136,674,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
299,910,387.80 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
632,569,291.86 |
| Total Liabilities |
2,741,769,107.91 |
| Paid-In Capital(Or Share Stock) |
936,060,590.00 |
| Capital Surplus |
1,479,614,431.16 |
| Surplus Reserve |
209,540,233.86 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,757,361,418.40 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,269,460,435.66 |
| Owner's Equity（Stockholder's Equity） |
5,269,460,435.66 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,011,229,543.57 |
